Effective vaccine safety systems in all countries: A challenge for more equitable access to immunization

Vaccine

Volumn 31, Issue SUPPL2, 2013, Pages

  Amarasinghe, Ananda ^a   Black, Steve ^a   Bonhoeffer, Jan ^a   Carvalho, Sandra M Deotti ^a   Dodoo, Alexander ^a   Eskola, Juhani ^a   Larson, Heidi ^a   Shin, Sunheang ^a   Olsson, Sten ^a   Balakrishnan, Madhava Ram ^a   Bellah, Ahmed ^a   Lambach, Philipp ^a   Maure, Christine ^a   Wood, David ^a   Zuber, Patrick ^a   Akanmori, Bartholomew ^a   Bravo, Pamela ^a   Pombo, María ^a   Langar, Houda ^a   Pfeifer, Dina ^a   Guichard, Stéphane ^a   Diorditsa, Sergey ^a   Hossain, Md Shafiqul ^a   Sato, Yoshikuni ^a   more..

^a NONE

Author keywords

Blueprint; Global Vaccine Safety; Global Vaccine Safety Initiative; GVSI; Immunization safety; Post marketing surveillance; Vaccine Safety

Indexed keywords

VACCINE;

DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; REVIEW; WORLD HEALTH ORGANIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; PHARMACOVIGILANCE; SAFETY; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 84876743804     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.119     Document Type: Review

References (33)

1. World Health Organization, United Nations Children's Fund (UNICEF), World Bank. State of the world's vaccines and immunization. 3rd ed. Geneva: WHO; 2009.
2. Chen R.T., Rastogi S.C., Mullen J.R., et al. The vaccine adverse event reporting system (VAERS). Vaccine 1994, 12:542-550.
3. Ellenberg S.S., Foulkes M.A., Midthun K., Goldenthal K.L. Evaluating the safety of new vaccines: summary of a workshop. American Journal of Public Health 2005, 95(May (5)):800-807.
4. GACVS and WHO secretariat Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. Expert Review of Vaccines 2009, 8:705-716.
5. Lilienfeld D.E. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902. Perspectives in Biology and Medicine 2008, 51(Spring (2)):188-198.
6. Pan American Health Organization Essential public health functions (document CD42/15) [online]. 42nd Directing Council, 52nd Session of the Regional Committee of the World Health Organization for the Americas 2000, PAHO, Washington DC.
7. World Health Organization Immunization and vaccine quality (resolution WHA45.17). 45th World Health Assembly 1992, WHO, Geneva.
8. World Health Organization Implementation of WHO's Revised Drug Strategy: Safety, efficacy, and quality of pharmaceuticals (Resolution WHA47.17). 47th World Health Assembly 1994, WHO, Geneva.
9. World Health Organization Quality and safety of medicines, including of blood products (document EB113/10). 113th Session of the Executive Board of the World Health Organization 2004, WHO, Geneva.
10. World Health Organization. Global vaccine safety blueprint-the landscape analysis. WHO IVB 12.04; 2012.
11. Djingarey M.H., Barry R., Bonkoungou M., et al. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience. Vaccine 2012, 30(Suppl. 2):B40-B45.
12. World Health Organization GACVS report: preparing for vaccine introduction in Africa and Asia. The Weekly Epidemiological Record 2011, 86:323-324.
13. CIOMS/WHO Report on Vaccine Pharmacovigilance (see also (last visited: July 2012). http://www.cioms.ch/frame_vaccine_pharmacovigilance.htm.
14. World Health Organization Meeting of the Strategic Advisory Group of Experts on Immunization, November 2011-conclusions and Recommendations. The Weekly Epidemiological Record 2012, 87:9-10.
15. World Health Organization GACVS: implementing the Global Vaccine Safety Blueprint. The Weekly Epidemiological Record 2012, 87:58-59.
16. Global Vaccine Action Plan. Vaccine 2013, 31:B5-B31. Decade of Vaccines Collaboration.
17. Graham J.E., Borda-Rodriguez A., Huzair F., Zinck E. Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine 2012, 30(July (33)):4953-4959. [Epub 2012 May 30].
18. World Health Organization. Global vaccine safety blueprint (2012). WHO/IVB/12.07; 2012.
19. World Health Organization. (last visited: July 2012). http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/index.html.
20. Ouandaogo C.R., Yaméogo T.M., Diomandé F.V., et al. Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso. Vaccine 2010, 30(Suppl. 2):B46-B51.
21. Chaibou M.S., Bako H., Salisou L., et al. Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010. Vaccine 2012, 30(June):5229-5234.
22. Patel M.M., López-Collada V.R., Bulhões M.M., et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. The New England Journal of Medicine 2011, 364:2283-2292.
23. Dodd C.N., Izurieta H.S., Zuber P., Romio S., Sturkenboom M., Hua W., Bonhoeffer J., Weibel D., Black S., The Global H1N1-GBS Working Group International Collaborative Case Series Safety Monitoring for Pandemic 2009 H1N1 Vaccines: Estimation of the Risk of Guillain-Barre Syndrome. Poster 778. 27th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2012.
24. Bairwa M., Rajput M., Khanna P., Rohilla R., Verma R., Chawla S. Malaria vaccine: a bright prospect for elimination of malaria. Human Vaccines & Immunotherapeutics 2012, 8(June (60)). [Epub ahead of print].
25. Konishi E. Issues related to recent dengue vaccine development. Tropical Medicine and Health 2011, 39(December (Suppl. 4)):63-71. [Epub 2011 Aug 6].
26. WHO, GACVS Global network for postmarketing surveillance and AEFI monitoring. The Weekly Epidemiological Record 2012, 87:57-58.
27. Uppsala Monitoring Centre. (last visited: July 2012). http://www.who-umc.org/.
28. World Health Organization GACVS report. The Weekly Epidemiological Record 2012, 87:281-828.
29. Brighton Collaboration. (last visited: July 2012). https://brightoncollaboration.org/public/what-we-do/standards/case-definitions.html.
30. WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance. (last visited: July 2012). http://pvtoolkit.org/.
31. Black S., Zuber P.L.F. Global trends and challenges in vaccine safety. Pediatric Health 2009, 3(August (4)):329-335.
32. INDEPTH network (last visited: July 2012). http://www.indepth-network.org/.
33. Larson H., et al. Addressing the vaccine confidence gap. Lancet 2011, 378(9790):526-535.